四环医药控股集团有限公司于2026年3月2日发布截至2026年2月28日的股份变动月报表。该公司注册股本在本月维持100,000,000,000股普通股，面值每股HKD0.01，总额HKD1,000,000,000。公告显示报告期内无新增发行、购回或注销股份活动。
本月末，公司已发行股份（不包括库存股份）总数维持在9,145,988,206股，另有184,011,000股库存股份，合计9,329,999,206股。根据公告，期内不存在新增发行或转让库存股份。公司于此前授出的两批购股权数量分别为60,586,000份（行使价HKD0.972）和7,500,000份（行使价HKD2.22），在2026年2月同样无行使及注销记录，期末相关购股权数量保持不变。
公告确认，截至报告期末公司已满足香港联交所规定的公众持股量要求，整体股本状况保持稳定。本次月报由执行董事及联席公司秘书陈燕玲签署。公司称将继续遵守香港联交所《上市规则》及相关法律法规的规定，确保信息披露的完整与透明度。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.